CryoPort, Inc.

  • Market Cap: Micro Cap
  • Industry: Transport Services
  • ISIN: US2290503075
USD
9.88
0.67 (7.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About CryoPort, Inc. stock-summary
stock-summary
CryoPort, Inc.
Transport Services
Cryoport, Inc. (Cryoport), is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Through its products and services the Company enable its clients to ship, store and deliver cellular-based materials and drug products as well as other life sciences commodities in a precise, defined temperature-controlled state. The Company’s advanced platform is comprised of comprehensive and technology-centric systems and solutions are designed to support the global high-volume distribution of commercial biologic and cell-based products and therapies regulated by the United States Food and Drug Administration (FDA) and other international regulatory bodies for distribution in the Americas, Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions.
Company Coordinates stock-summary
Company Details
112 Westwood Pl Ste 350 , BRENTWOOD TN : 37027-5332
stock-summary
Tel: 1 949 23219001 212 6826300
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 58 Schemes (41.84%)

Foreign Institutions

Held by 93 Foreign Institutions (22.85%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Jerrell Shelton
Chairman of the Board, President, Chief Executive Officer
Mr. Richard Berman
Lead Independent Director
Mr. Daniel Hancock
Director
Mr. Ram Jagannath
Director
Dr. Robert Hariri
Independent Director
Dr. Ramkumar Mandalam
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
45 Million
(Quarterly Results - Jun 2025)
Net Profit:
-12 Million
stock-summary
Industry

Transport Services

stock-summary
Market cap

USD 503 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.46

stock-summary
Return on Equity

-10.37%

stock-summary
Price to Book

0.98